PDA survey and conference discussion will generate information to guidance on technology transfer.
The Parenteral Drug Association (PDA) announced plans to release the results of its 2019 Technology Transfers Survey during the 2019 PDA Annual Meeting at the Marriott Marquis San Diego, Calif., March 11–13, 2019.
The organization is working on initiatives relating to technology transfers, gathering data to better understand how companies implement technology transfers, and the challenges encountered, according to a PDA press announcement on Feb. 1, 2019. The survey results and discussion at the conference may be included in a potential revision of PDA Technical Report No. 65: Technology Transfer and used to develop additional guidance on the topic.
The survey results will be discussed at the Technology Transfer Interest Group session on Tuesday, March 12, 2019 and will include information on technology transfer benchmarking, tools, and tips.
Each session at the 2019 PDA Annual Meeting: Solving Manufacturing and Supply Challenges for Current and Future Medicinal Products is designed to engage attendees in discussions on improving existing processes or entirely new technologies and therapies.
Source: Parenteral Drug Association
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.